Now Available from Aniara Diagnostica: Xenometrix Rapid MicroNucleus MoA
Aniara Diagnostica is pleased to announce the availability of Xenometrix Rapid MicroNucleus MoA-One-hour FISH MicroNucleus Assay for reliable Genotoxicity Assessment. For Research Use Only. Not for use in diagnostic procedures.
WEST CHESTER, Ohio, June 2, 2020 /PRNewswire-PRWeb/ -- Aniara Diagnostica, a multi-national distributor of diagnostic and research agents, as well as screening tools, has strengthened its commitment to meeting today's highest standards for product quality and cost-efficient delivery.
Xenometrix products are made for use in molecular pharmacology, early stages of drug discovery, screening of chemical, cosmetic, alimentary, or agrochemical compounds, and for testing environmental water, soil, air, or effluents.
Rapid MicroNucleus MoA is designed for an easier and reliable detection of all repeated human centromere sequences with a high efficiency and strong signal. Rapid MicroNucleus MoA permits the user identify the nature of substances (or exposure) (Aneugens and Clastogens) in addition to the scoring of micronuclei in line with TG OECD 487.
These kits provide all key reagents needed to perform fluorescence in situ hybridization for the detection of centromere sequences by microscopy
AM020 Rapid MicroNucleus MoA (20 tests) click here for more information
AM100 Rapid MicroNucleus MoA (100 tests) click here for more information
Aniara also offers a full range of Ames kits including Ames MPF and Ames II click here for more information
The entire Aniara product line is available for purchase at http://www.aniara.com. The Company distributes products in North America, Central America, South America, Sweden, Norway, Denmark, Finland, Lithuania, Latvia, Estonia and Iceland.
SOURCE Aniara Diagnostica
Share this article